title: Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells.
abstract: BACKGROUND
  The management of hormone-insensitive locally advanced prostate cancer is difficult and complex and there is an urgent need for the development of effective chemotherapeutic agents intended for combination with currently available treatment modalities.
  
  
  METHODS
  The present paper demonstrates the effectiveness of the monoterpene perillyl alcohol (POH) as potent radiosensitizer on DU145 and PC3 cell lines by performing clonogenic survival assays, cycle analysis, and assays to detect viability, apoptosis, and Fas receptor/ligand by flow cytometry.
  
  
  RESULTS
  POH pretreatment resulted in a dose dependent sensitization to kill cell by radiation. Furthermore, POH treatment induced a transient G(2)/M arrest, enhanced the expression of the membrane bound form of the Fas ligand and sensitized the cells to Fas mediated apoptosis.
  
  
  CONCLUSIONS
  The unique manner of radiosensitization in addition to its low toxicity profile makes POH a promising new agent for preclinical evaluation as a potential radiosensitizer in the treatment of prostate cancer.
authors.affiliation: Department of Human Oncology, Medical School, University of Wisconsin, Madison, Wisconsin, USA.
authors.forename: Deepika
authors.initials: D
authors.lastname: Rajesh
authors.forename: Steven P
authors.initials: SP
authors.lastname: Howard
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects; D019926:Cyclin B / Q000378:metabolism; D056741:Cyclin D; D016213:Cyclins / Q000378:metabolism; D016195:G2 Phase / Q000187:drug effects; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects; D039821:Monoterpenes / Q000494:pharmacology*; D011471:Prostatic Neoplasms; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D019014:fas Receptor / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D019926:Cyclin B; D056741:Cyclin D; D016213:Cyclins; D008565:Membrane Proteins; D039821:Monoterpenes; D011838:Radiation-Sensitizing Agents; D019014:fas Receptor; C032208:perillyl alcohol